Cortrosyn Related Published Studies
Well-designed clinical trials related to Cortrosyn (Cosyntropin)
Cosyntropin for prophylaxis against postdural puncture headache after accidental dural puncture. [2010.08]
Basal and cosyntropin-stimulated plasma cortisol concentrations, as measured by high-performance liquid chromatography, in children aged 5 months to younger than 6 years. [2007.06]
Well-designed clinical trials possibly related to Cortrosyn (Cosyntropin)
The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. [2011.07]
Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. [2010.05]
Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild asthma. [2010.01]
Mometasone furoate nasal spray is safe and effective for 1-year treatment of children with perennial allergic rhinitis. [2009.05]
Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension. [2009.04]
The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis. [2009.03]
[Melatonin reduces cortisol response to ACTH in humans] [2008.11]
Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. [2008.09]
Moderate weight loss reduces renin and aldosterone but does not influence basal or stimulated pituitary-adrenal axis function. [2007.09]
Combining growth hormone releasing hormone-arginine and synacthen testing diminishes the cortisol response. [2007.03]
Intramuscular administration of a low dose of ACTH for ACTH stimulation testing in dogs. [2006.08.15]
Increased adrenal androgen secretion with inhibition of 11beta-hydroxylase in HIV-infected women. [2006.05]
Daily and photoperiod variations of hypothalamic-pituitary-adrenal axis responsiveness in Japanese quail selected for short or long tonic immobility. [2005.12]
Effect of dose on response to adrenocorticotropin in extremely low birth weight infants. [2005.12]
Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma. [2005.12]
The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. [2005.11]
Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma. [2005.09]
Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma. [2005.04]
Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze. [2005.01]
The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. [2004.11.13]
Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis. [2004.07]
Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function. [2004.03]
Synacthen Depot for the treatment of postdural puncture headache. [2004.02]
No major effect of orciprenaline and propranolol upon ACTH-induced cortisol secretion. [2004.01]
Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants. [2003.10]
Lack of long-term adverse adrenal effects from inhaled triamcinolone: Lung Health Study II. [2003.07]
Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma. [2003.05]
Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. [2003.04]
Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. [2002.09]
One-year trial on safety and normal linear growth with flunisolide HFA in children with asthma. [2002.06]
A comparison of non-tapering vs. tapering prednisolone in acute exacerbation of asthma involving use of the low-dose ACTH test. [2002.06]
Adrenocorticotropin stimulation tests in patients with hypothalamic-pituitary disease: low dose, standard high dose and 8-h infusion tests. [2001.11]
Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. [2001.11]
Early rise in blood pressure following administration of adrenocorticotropic hormone-[1-24] in humans. [2001.09]
Fecal corticosterone reflects serum corticosterone in Florida sandhill cranes. [2001.07]
Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler. [2001.01]
Adrenocortical dysfunction following etomidate induction in emergency department patients. [2001.01]
Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses. [2000.12]
Meter-dosed, inhaled beclomethasone initiated at birth to prevent bronchopulmonary dysplasia. [2000.10]
A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma. [2000.08]
Stimulatory effects of stress on gonadotropin secretion in estrogen-treated women. [2000.06]
Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. [2000.02]
Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. [2000.02]
Inpatient treatment of rheumatoid arthritis with synacthen depot: a double blind placebo controlled trial with 6 month followup. [1999.12]
Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests. [1999.10]
Adrenocortical responses and family history of alcoholism. [1999.07]
A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis. [1999.07]
Adrenal function in premature infants during inhaled beclomethasone therapy. [1999.07]
Evaluation of a low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dogs and dogs with naturally developing hyperadrenocorticism. [1999.05.15]
Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone. [1999.05]
Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis. [1999.04]
Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. [1999.03]
Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma. [1999.02]
Serum corticosterone response to adrenocorticotropic hormone stimulation in Florida sandhill cranes. [1998.10]
Recurrent hypoglycemia does not impair the cortisol response to adrenocorticotropin infusion in healthy humans. [1998.10]
Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. [1998.09.23]
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. [1998.08.06]
Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis. [1998.08]
Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol. [1998.06]
Late feedback effects of hypothalamic-pituitary-adrenal axis hormones in healthy subjects. [1998.05]
Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. [1998.04]
Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study. [1998.03]
A systemic bioactivity comparison of double-strength and regular-strength beclomethasone dipropionate MDI formulations. [1998.01]
A pilot study of steroid therapy after emergency department treatment of acute asthma: is a taper needed? [1998.01]
Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group. [1998.01]
Effects of antidepressant treatment on corticotropin-induced cortisol responses in patients with melancholic depression. [1997.11.14]
Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients. [1997.11.05]
Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children. [1997.11]
Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression. [1997.07.15]
Effect of five days of dexamethasone therapy on ventilator dependence and adrenocorticotropic hormone-stimulated cortisol concentrations. [1997.01]
Pituitary-adrenal response to RU 486 in man. [1997]
A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis. [1996.07]
Fluticasone propionate: topical or systemic effects? [1996.05]
Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis. [1995.07]
Assessing the hypothalamo-pituitary-adrenal axis in patients on long-term glucocorticoid therapy: the short synacthen versus the insulin tolerance test. [1995.04]
The combined corticotropin-releasing hormone/lysine vasopressin test discloses a corticotroph phenotype. [1994.08]
A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma. [1994.05]
Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation. [1994.02]
Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. [1993.09]
Dose response relationship between plasma ACTH and cortisol after the infusion of ACTH1-24. [1993]
A comparative study of the effects of intranasal triamcinolone acetonide aerosol (ITAA) and prednisone on adrenocortical function. [1992.06]
Adrenal function in adult asthmatics during long-term daily treatment with 800, 1,200, and 1,600 micrograms triamcinolone acetonide. Multicenter study. [1992.05]
Cromolyn versus triamcinolone acetonide for youngsters with moderate asthma. [1991.11]
Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. [1991.09]
Adrenal androgen secretion in postadolescent acne: increased adrenocortical function without hypersensitivity to adrenocorticotropin. [1991.08]
Tetracosactrin vs. methylprednisolone in the prevention of emesis in patients receiving FEC regimen for breast cancer. [1991]
[Comparison of the antiemetic effectiveness of high-dose corticosteroids with synacthene in nausea induced by chemotherapy: results of a randomized study] [1989]
[A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin] [1989]
Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis. [1988.04]
Steroids and neuroendocrine function in anorexia nervosa. [1987]
Other research related to Cortrosyn (Cosyntropin)
Comparison of low-dose and high-dose cosyntropin stimulation testing in children. [2011.04]
Cortisol and aldosterone response to various doses of cosyntropin in healthy cats. [2011.01.15]
Is the cosyntropin test redundant in the acutely ill patient suspected of adrenal insufficiency? A case report and literature review. [2010.09]
The low-dose (1 microg) cosyntropin test (LDT) for primary adrenocortical insufficiency: Defining the normal cortisol response and report on first patients with Addison disease confirmed with LDT. [2010.03]
Cosyntropin for prophylaxis against postdural puncture headache after accidental
dural puncture. [2010]
[Cosyntropin test in severe active tuberculosis.] [2008.07]
Diagnosing adrenal insufficiency: which test is best--the 1-microg or the 250-microg cosyntropin stimulation test? [2008.03]
A case of Addison's disease confirmed with low dose cosyntropin stimulation test. [2007.12]
Effect of low doses of cosyntropin on serum cortisol concentrations in clinically normal dogs. [2007.05]
|
